✦ LIBER ✦

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy

✍ Scribed by Huang, Yi-Teng; Li, Fei-Fei; Ke, Chen; Li, Zhou; Li, Zong-Tai; Zou, Xiao-Fang; Zheng, Xiao-Xuan; Chen, Yu-Ping; Zhang, Hao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LGR5 is a biomarker for stratification o

✍ Chen, Chan; Zhang, Cheng; Xu, Jun-Mei; Han, Yong 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 771 KB

CDO1 Promoter Methylation is a Biomarker

✍ Dimo Dietrich; Manuel Krispin; Jörn Dietrich; Anne Fassbender; Jörn Lewin; Nadia 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 704 KB

Predicting for activity of second-line t

✍ Rupert Bartsch; Catharina De Vries; Ursula Pluschnig; Peter Dubsky; Zsuzsanna Ba 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 644 KB

156 Positive HER2 status – Is it a discr

✍ S. Susnjar; T. Vujasinovic; Z. Abu Rabi; Z. Neskovic-Konstantinovic; Z. Milovano 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Clinical outcomes in patients who receiv

✍ Kaplan, Muhammet Ali; Isikdogan, Abdurrahman; Koca, Doğan; Kucukoner, Mehmet; Gu 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 245 KB